Episode

Unlocking Mitochondrial Magic – The Peptide SS-31 and the Quest for Age-less Vitality

Podcast
The Science of Age-less Living
Published
Nov 27, 2025
Duration seconds
1930
Processing state
not_requested
Canonical source
https://rss.com/podcasts/the-science-of-age-less-living/2352069
Audio
https://content.rss.com/episodes/319089/2352069/the-science-of-age-less-living/2025_11_27_17_26_23_77ff8d32-2aab-4787-ba27-c2013c7b0a44.mp3
JSON
/v1/public/podcasts/the-science-of-age-less-living-7235688/episodes/unlocking-mitochondrial-magic-the-peptide-ss-31-and-the-quest-for-age-less-vitality
Markdown
/podcast/the-science-of-age-less-living-7235688/unlocking-mitochondrial-magic-the-peptide-ss-31-and-the-quest-for-age-less-vitality.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-science-of-age-less-living-7235688/episodes/unlocking-mitochondrial-magic-the-peptide-ss-31-and-the-quest-for-age-less-vitality/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-science-of-age-less-living-7235688/unlocking-mitochondrial-magic-the-peptide-ss-31-and-the-quest-for-age-less-vitality.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Dive into SS-31 Explained: Unlock Youthful Energy at the Mito Level — a 6:45 deep-dive on SS-31 (Elamipretide), mitochondrial health, and the latest 2025 clinical updates. Dr. Ethan breaks down mechanisms, preclinical wins, human trials, safety, and real-world anti-aging potential for longevity seekers (35–65). Learn how SS-31 targets cardiolipin, reduces ROS, boosts ATP, and why FDA approval for Barth syndrome matters for mitochondrial medicine. Perfect for anyone curious about mitochondrial dysfunction, sarcopenia, HFpEF, AMD, and translational longevity science. Like and share if you found this useful. #SS31 #Elamipretide #Mitochondria #Longevity #AntiAging #BarthSyndrome #MitochondrialHealth OUTLINE: 00:00:00 Opening and Episode Intro 00:01:32 Chapter 1 - Introducing SS-31 00:07:06 Chapter 2 - Mechanism 00:13:45 Chapter 3 - Preclinical Studies 00:21:14 Chapter 4 - Human Trials 00:26:31 Chapter 5 - Age-less Living Benefits 00:28:46 Chapter 6 - Safety 00:30:14 Chapter 7 - Future Outlook 00:31:13 Chapter 8 - Wrap Up